Report Description Report Description and Highlights

Global Infection Surveillance Solutions Market Research Report 2023-2028:

According to the latest report by IMARC Group, titled " InfectionSurveillanceSolutionsMarket:GlobalIndustryTrends,Share,Size,Growth,Opportunitya ndForecast2023-2028

," the global infection surveillance solutions market size reached US$ 580.9 Million in 2022.

Infection surveillance solutions are generally utilized by healthcare professionals for the systematic collection and interpretation of health-related data. They assist in evaluating and monitoring the epidemiology of health problems, planning public health policies and strategies, and guiding priority settings.

Additionally, they are also used for determining infection trends and shifts in microbial pathogens while providing healthcare institutions with accurate data on patient and employee surgical and health databases with real-time monitoring. Due to rapid digitization across the healthcare sector, there has been a considerable rise in the adoption of infection surveillance solutions across the globe. Request for a PDF sample of this report: https://www.imarcgroup.com/infection-surveillance-solutions-market/requestsample

Global Infection Surveillance Solutions Market Trends:

The global market is primarily driven by the increasing prevalence of virus-acquired infections. This is supported by the escalating need for continuous monitoring and interpretation of health-related data for the accurate implementation of preventive solutions in order to control the spread of diseases. Coupled with the rapid outbreak of the coronavirus disease (COVID-19), this has further propelled the market growth. Moreover, numerous initiatives undertaken by the government of multiple countries in order to improve the quality of patient care and safety are providing a boost to the demand for infection surveillance systems across the globe. In line with this, the rising investments and funding activities by private and public agencies for the deployment of advanced infection surveillance are creating a positive market outlook. Other factors, including continuous improvements in the healthcare and information technology (IT) infrastructures, the growing preference for cloud-based software, and extensive research and development activities (R&D) conducted by key players, are also positively influencing the market. Looking forward, IMARC Group expects the market to reach a value of US$ 1,177.7 Million by 2028, exhibitingataCAGRof12.1%during2023-2028.

View Report TOC, Figures and Tables: https://www.imarcgroup.com/infection-surveillance-solutions-market